middle.news
Proteomics International funds its commercial leap with discounted SPP
9:12am on Monday 2nd of November, 2026 AEDT
•
Healthcare
Read Story
Proteomics International funds its commercial leap with discounted SPP
9:12am on Monday 2nd of November, 2026 AEDT
Key Points
A$5 million SPP at A$0.10 per share
12.2% discount to five-day VWAP
One free option per share, subject to shareholder approval
Funding targeted at Healius rollout, clinical evidence and US readiness
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE